Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Periodontitis may increase the risk of developing alopecia areata.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

A deep learning model accurately detects early hair loss signs using scalp images.

The model accurately detects early-stage hair loss using images.

Dengue symptoms and liver issues can persist for over two months, especially in men.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Alopecia areata greatly affects the quality of life for children and their families.

Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.

Most children with MIS-C showed significant improvement by 6 months.

Improving diet may help manage sleep disorders.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Stabilization of fibrosing alopecia may not mean effective disease control.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Low-dose finasteride may increase erectile dysfunction risk over time.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Long-COVID symptoms like fatigue, cognitive issues, and mobility problems can last 6-12 months but are less common after milder illness.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

GLP-1RA therapy may increase the risk of hair loss.